Scenarios that move MED

MEDIFAST INC Common Stock

Scenarios that move MED: 2 analyses, 0 positive, 2 negative.

  1. · Viking Therapeutics advances oral obesity drug to Phase III — ▼ · impact -24 · confidence low · horizon quarters
  2. · Lilly reports strong weight loss results for new drug — ▼ · impact -40 · confidence low · horizon quarters

All scenarios · Run a scenario · Pricing